Pharmacogenetics-guided Isoniazid Dosing in TB-HIV
Condition(s):TuberculosisLast Updated:January 25, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):TuberculosisLast Updated:January 25, 2022Recruiting
Condition(s):Silicosis TuberculosisLast Updated:April 5, 2019Recruiting
Condition(s):Tuberculosis; HIV InfectionsLast Updated:February 6, 2014Completed
Condition(s):Tuberculosis; Drug-Induced Liver Injury; Adverse Drug EventLast Updated:February 28, 2020Completed
Condition(s):HIV Seropositivity; Pregnancy; Tuberculosis InfectionLast Updated:November 16, 2021Not yet recruiting
Condition(s):HIVLast Updated:June 21, 2017Unknown status
Condition(s):Infertility, Female; Recurrent Implantation Failure; Genital Tuberculoses, Female; Genital Tuberculosis, LatentLast Updated:August 27, 2020Not yet recruiting
Condition(s):HepatotoxicityLast Updated:March 17, 2014Unknown status
Condition(s):Pulmonary TuberculosisLast Updated:February 28, 2011Terminated
Condition(s):Tuberculosis; HIVLast Updated:October 30, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.